Sonoma Biotherapeutics Stock

Invents personalized T cell therapies for autoimmune diseases.

Buy

Buy Sonoma Biotherapeutics shares

Sign up to view historical trading trends and place an offer.

Sell

Sell Sonoma Biotherapeutics shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Overview

Sonoma Biotherapeutics is inventing the future of living therapies for autoimmune disease — safe, effective treatments as unique as each individual patient. Regulatory T cell therapies that harness a patient’s own immune cells, powerful next generation gene editing techniques and advanced manufacturing and quality assurance processes. Sonoma’s mission is to create a best-in-class regulatory T cell therapy that delivers long-lasting, highly efficacious treatments leading to cures across a spectrum of autoimmune and degenerative diseases.

Sector

Healthcare & Life Sciences

Founded

2019

Headquarters

South San Francisco, CA

Buy

Buy Sonoma Biotherapeutics shares

Sign up to view historical trading trends and place an offer.

Sell

Sell Sonoma Biotherapeutics shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Sonoma Biotherapeutics Management Team

Sonoma Biotherapeutics people and management

  • Co-Founder, CEO, President, Board Member
    Jeffrey Bluestone
  • Co-Founder
    Alexander Rudensky
  • Co-Founder
    Fred Ramsdell
  • Co-Founder
    Qizhi Tang
  • Board Member
    Carlos Solórzano
  • Board Member
    John C. Davis
  • Board Member
    Maggie Wilderotter
  • Board Member
    Richard Klausner
  • Board Member
    Terry Rosen
  • Board Member
    Toni Hoover

Investors

Major Sonoma Biotherapeutics investors

  • 8VC

  • Alexandria Venture Investments

  • Ally Bridge Group

  • ARCH Venture Partners

  • ArrowMark Partners

  • Avidity Partners

  • Casdin Capital

  • Deep Track Capital

  • Fidelity Management and Research Co.

  • Frazier Healthcare Ventures

  • Google Ventures

  • Janus Henderson

  • JDRF T1D Fund

  • LifeForce Capital

  • Lilly Asia Ventures

  • Lyell Immunopharma

  • Milky Way Ventures

  • Mirae Asset Capital

  • NS Investment

  • Octagon Investments

  • Osage University Partners

  • Piper Heartland Healthcare Capital

  • Vertex Ventures

Sonoma Biotherapeutics Valuations & Financials

Gain Insights Into Sonoma Biotherapeutics Stock Valuation & Share Prices

View real-time NPM data on Sonoma Biotherapeutics stock including daily Sonoma Biotherapeutics stock price estimates, valuation history, and historical share price information. Access Sonoma Biotherapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Sonoma Biotherapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Sonoma Biotherapeutics? Get in touch to learn more.

Similar Companies

Explore companies

like Sonoma Biotherapeutics

  • Revitope Oncology

    Healthcare & Life Sciences

    Develops dual-targeting immunotherapy platform for cancer treatment, enhancing precision and reducing side effects through selective targeting.

  • Lifemed

    Healthcare & Life Sciences

    Utilizes AI to automate claims management and enhance patient check-in processes, improving operational efficiency.

  • Celsius

    Healthcare & Life Sciences

    Company providing advanced energy storage solutions that enhance performance and sustainability for large-scale applications.

  • Shoulder Innovations

    Healthcare & Life Sciences

    Develops advanced shoulder replacement implants and solutions, focusing on innovative designs that enhance patient mobility and durability.

  • Sherlock Biosciences

    Healthcare & Life Sciences

    Develops molecular diagnostic solutions using CRISPR and synthetic biology to enable rapid, accessible DNA and RNA testing.

  • Expansion Therapeutics

    Healthcare & Life Sciences

    Biotech company develops oral medicines targeting RNA to treat neurological disorders using small molecule technology.

  • InterVene

    Healthcare & Life Sciences

    Creates a thrombectomy platform which clears obstructed veins and supports long-term patency.

  • Tasca Therapeutics

    Healthcare & Life Sciences

    Biotechnology company developing small molecule inhibitors targeting auto-palmitoylated proteins to fight cancer with first-in-class drug candidates.

  • WINPRO Pet

    Healthcare & Life Sciences

    Provides pet supplements that support health and reduce inflammation using plasma-based ingredients and natural formulations.

FAQ

Questions?

We have answers

Buy Sonoma Biotherapeutics Stock

Sonoma Biotherapeutics stock does not trade on public stock exchanges. Sonoma Biotherapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Sonoma Biotherapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Sonoma Biotherapeutics Stock

Sonoma Biotherapeutics Stock does not trade on public stock exchanges. In order to sell Sonoma Biotherapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

 

Sonoma Biotherapeutics Stock Price

Sonoma Biotherapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Sonoma Biotherapeutics share price and other valuable private market data.

Read more about secondary market private company stock prices:

Sonoma Biotherapeutics Stock Ticker Symbol

There is no ticker symbol for Sonoma Biotherapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Sonoma Biotherapeutics Stock

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Sonoma Biotherapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

 

Criteria to Buy or Invest in Sonoma Biotherapeutics Stock

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Sonoma Biotherapeutics stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Sonoma Biotherapeutics Stock Settlement

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Sonoma Biotherapeutics IPO

Sonoma Biotherapeutics is a private company and has not had an IPO. There is currently no Sonoma Biotherapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Sonoma Biotherapeutics IPO.

Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.